स्पेन - स्पेनी - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

bimeda animal health limited - ivermectina - soluciÓn inyectable - ivermectina 10 - ivermectina, combinaciones - bovino

स्पेन - स्पेनी - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

norbrook laboratories (ireland) limited - imidacloprid - soluciÓn para unciÓn dorsal puntual - - combinaciones con moxidectina - gatos; hurones

स्पेन - स्पेनी - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

norbrook laboratories (ireland) limited - imidacloprid - soluciÓn para unciÓn dorsal puntual - - combinaciones con moxidectina - gatos

पेरू - स्पेनी - DIGEMID (Dirección General de Medicamentos, Insumos y Drogas)

msn labs peru s.a.c. - droguerÍa - monohidrato de bosentan; - tableta recubierta - por vial 1.00 tab - - bosentano

ग्वाटेमाला - स्पेनी - Gobierno de Guatemala, Ministerio de Salud Pública y Asistencia Social (Departamento de Regulación y Control de Productos Farmacéuticos y Afines)

msn laboratories private limited - comprimido recubierto - 125 mg

यूरोपीय संघ - स्पेनी - EMA (European Medicines Agency)

taw pharma (ireland) limited - clorhidrato de clopidogrel - peripheral vascular diseases; stroke; myocardial infarction; acute coronary syndrome - agentes antitrombóticos - , , , , secondary prevention of atherothrombotic events, , clopidogrel is indicated in: , - adult patients suffering from myocardial infarction (from a few days until less than 35 days), ischaemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease. , - adult patients suffering from acute coronary syndrome:,    - non-st segment elevation acute coronary syndrome (unstable angina or non-q-wave myocardial infarction), including patients undergoing a stent placement following percutaneous coronary intervention, in combination with acetylsalicylic acid (asa). ,     - st segment elevation acute myocardial infarction, in combination with asa in medically treated patients eligible for thrombolytic therapy. , , in patients with moderate to high-risk transient ischaemic attack (tia) or minor ischaemic stroke (is), clopidogrel in combination with asa is indicated in:, - adult patients with moderate to high-risk tia (abcd2  score ≥4) or minor is (nihss  ≤3) within 24 hours of either the tia or is event.  , , prevention of atherothrombotic and thromboembolic events in atrial fibrillation, in adult patients with atrial fibrillation who have at least one risk factor for vascular events, are not suitable for treatment with vitamin k antagonists (vka) and who have a low bleeding risk, clopidogrel is indicated in combination with asa for the prevention of atherothrombotic and thromboembolic events, including stroke. , , for further information please refer to section 5. , , ,.

यूरोपीय संघ - स्पेनी - EMA (European Medicines Agency)

pfizer limited  - metaflumizone, amitraz - ectoparasiticides para uso tópico, incl. los insecticidas - perros - para el tratamiento y prevención de infestaciones por pulgas (ctenocephalides canis y c. felis) y garrapatas (ixodes ricinus, ixodes hexagonus, rhipicephalus sanguineus, dermacentor reticulatus y dermacentor variabilis), y el tratamiento de la infección (causada por demodex spp. ) y piojos (trichodectes canis) en perros. el medicamento veterinario se puede utilizar como parte de una estrategia de tratamiento para la dermatitis alérgica a las pulgas (fad).

स्पेन - स्पेनी - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

eco animal health europe limited - ivermectina - soluciÓn inyectable - ivermectina 10 - ivermectina - bovino; ovino; porcino

स्पेन - स्पेनी - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

eco animal health europe limited - ivermectina - soluciÓn inyectable - ivermectina 1 - ivermectina - bovino; ovino; porcino

यूरोपीय संघ - स्पेनी - EMA (European Medicines Agency)

viatris limited - besilato de clopidogrel - peripheral vascular diseases; stroke; myocardial infarction - agentes antitrombóticos - secondary prevention of atherothrombotic events clopidogrel is indicated in:adult patients suffering from myocardial infarction (from a few days until less than 35 days), ischemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease. adult patients suffering from acute coronary syndrome. non-st segment elevation acute coronary syndrome (unstable angina or non-q-wave myocardial infarction), including patients undergoing a stent placement following percutaneous coronary intervention, in combination with acetylsalicylic acid (asa). elevación del segmento st infarto agudo de miocardio, en combinación con aas en los pacientes tratados médicamente elegibles para la terapia trombolítica. in patients with moderate to high-risk transient ischaemic attack (tia) or minor ischaemic stroke (is) clopidogrel in combination with asa is indicated in:adult patients with moderate to high-risk tia (abcd2 score ≥4) or minor is (nihss ≤3) within 24 hours of either the tia or is event. prevention of atherothrombotic and thromboembolic events in atrial fibrillation:in adult patients with atrial fibrillation who have at least one risk factor for vascular events, are not suitable for treatment with vitamin k antagonists (vka) and who have a low bleeding risk, clopidogrel is indicated in combination with asa for the prevention of atherothrombotic and thromboembolic events, including stroke. para más información, por favor refiérase a la sección 5.